
NVIDIA (NVDA) remains a foundational investment opportunity as its 97% year-over-year revenue growth expands beyond silicon into high-margin software frameworks, autonomous vehicle tech, and global data center partnerships.
Investors can capitalize on critical hardware bottlenecks by targeting essential upstream suppliers, specifically Taiwan Semiconductor Manufacturing Company (TSM) for advanced chip packaging, Corning (GLW) for specialized substrates, and Lumentum (LITE) for optical networking.
To trade the multi-decade AI energy constraint, allocate capital toward power generation utilities, electrical grid infrastructure, and agile neo-cloud providers that control scarce land and power assets.
In healthcare, pharmaceutical leaders Eli Lilly (LLY) and Merck (MRK) offer strong growth potential as they adopt biological foundation models to shorten clinical drug development timelines and reduce research and development failure rates.
Looking ahead to intensifying global hardware competition by 2030, investors should also begin positioning for value migrating toward domain-specific AI application software and companies leveraging open-source foundation models.

By @allin
Chamath Palihapitiya, Jason Calacanis, David Sacks & David Friedberg cover all things economic, tech, political, social & poker.